Founded in 2015, Adare Pharmaceuticals is the result of the strategic union of several renowned pharmaceutical companies. This merger combined decades of scientific and industrial expertise to form a global player committed to the development of innovative medicines, specialized medical devices and advanced therapeutic solutions. Today, Adare markets over 40 products in more than 100 countries, and pursues its mission to improve patient health through cutting-edge technologies.
At the heart of its strategy lies a clear objective: to offer treatments that meet unmet medical needs, by developing unique formulations that optimize the release, efficacy and tolerability of active ingredients.
One of Adare Pharmaceuticals' key assets is its mastery of controlled and targeted release technologies for active ingredients. These technological platforms enable :
Thanks to these innovations, Adare develops medicines that optimize clinical results while enhancing patient comfort, whether in pediatrics, geriatrics or chronic pathologies.
Adare Pharmaceuticals has diversified to cover several strategic therapeutic areas, with a particular focus on chronic diseases, rare diseases and gastrointestinal disorders.
One of the laboratory's flagship products is indicated for the treatment of rheumatoid arthritis, an autoimmune disease causing chronic joint inflammation. Thanks to an innovative formulation, the active ingredient is specifically targeted at the cells responsible for inflammation, significantly reducing pain and slowing disease progression.
Adare has developed a range of medical nutrition products for patients suffering from digestive disorders or inflammatory bowel syndromes. These formulas contain specific ingredients, selected for their ability to reduce inflammation, promote regeneration of the intestinal mucosa and improve digestive comfort.
In response to the needs of patients suffering from atopic dermatitis and other chronic skin disorders, Adare also offers targeted dermatological care products. These products aim to soothe itching, reduce irritation and strengthen the skin barrier, while being adapted to sensitive skin.
A strong commitment to research and development
Research and development (R&D) is at the heart of Adare Pharmaceuticals' mission. The company invests heavily in :
In collaboration with universities, research institutes and healthcare professionals around the world, Adare conducts rigorous clinical trials to assess the efficacy, safety and tolerability of its products.
Adare Pharmaceuticals also places sustainability and social responsibility at the heart of its strategy:
At the same time, the laboratory supports the continuing education of healthcare professionals by organizing conferences, funding research grants and sharing the latest scientific advances in its areas of expertise.
Adare relies on a collaborative approach to meet today's medical challenges. We work closely with :
This strategy enables us to cross-fertilize our expertise andaccelerate the development of relevant therapeutic solutions, while ensuring irreproachable pharmaceutical quality. The company also adapts to the evolving regulatory constraints of the pharmaceutical sector, keeping a constant watch to ensure the conformity of its products on international markets.
Despite facing intense competition and complex regulation, Adare Pharmaceuticals remains resolutely focused on innovation. Planned areas of development include :
Thanks to its advanced technologies, commitment to research and patient-focused vision, Adare Pharmaceuticals is a key player in the evolution of healthcare. Its products meet real medical needs, with the constant aim of improving the quality of life of patients worldwide.
With over 40 products already on the market, a presence in more than 100 countries, and an ambitious roadmap for the years ahead, Adare Pharmaceuticals continues to push back the boundaries of modern medicine, combining science, responsibility and therapeutic performance.
